Literature DB >> 32240922

Upregulated tumor necrosis factor-α transcriptome and proteome in adipose tissue-derived mesenchymal stem cells from pigs with metabolic syndrome.

Aditya S Pawar1, Alfonso Eirin1, Hui Tang1, Xiang-Yang Zhu1, Amir Lerman2, Lilach O Lerman3.   

Abstract

INTRODUCTION: Mesenchymal stem cells (MSCs) have endogenous reparative properties, and may constitute an exogenous therapeutic intervention in patients with chronic kidney disease. The microenvironment of metabolic syndrome (MetS) induces fat inflammation, with abundant expression of tumor necrosis factor (TNF)-α. MetS may also alter the content of adipose tissue-derived MSCs, and we hypothesized that the inflammatory profile of MetS manifests via upregulating MSC mRNAs and proteins of the TNF-α pathway.
METHODS: Domestic pigs were fed a 16-week Lean or MetS diet (n = 4 each). MSCs were harvested from abdominal subcutaneous fat, and their extracellular vesicles (EVs) isolated. Expression profiles of mRNAs and proteins in MSCs and EVs were obtained by high-throughput sequencing and proteomics. Nuclear translocation of the pro-inflammatory transcription factor (NF)-kB was evaluated in MSC and in pig renal tubular cells (TEC) co-incubated with EVs.
RESULTS: We found 13 mRNAs and 4 proteins in the TNF-α pathway upregulated in MetS- vs. Lean-MSCs (fold-change > 1.4, p < 0.05), mostly via TNF-α receptor-1 (TNF-R1) signaling. Three mRNAs were upregulated in MetS-EVs. MetS-MSCs, as well as TECs co-incubated with MetS-EVs, showed increased nuclear translocation of NF-kB. Using qPCR, JUNB, MAP2K7 and TRAF2 genes followed the same direction of RNA-sequencing findings.
CONCLUSIONS: MetS upregulates the TNF-α transcriptome and proteome in swine adipose tissue-derived MSCs, which are partly transmitted to their EV progeny, and are associated with activation of NF-kB in target cells. Hence, the MetS milieu may affect the profile of endogenous MSCs and their paracrine vectors and limit their use as an exogenous regenerative therapy. Anti-inflammatory strategies targeting the TNF-α pathway might be a novel strategy to restore MSC phenotype, and in turn function.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mesenchymal stem cells; Metabolic syndrome; Proteins; Tumor necrosis factor; mRNA

Year:  2020        PMID: 32240922     DOI: 10.1016/j.cyto.2020.155080

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

1.  A comparative study on normal and obese mice indicates that the secretome of mesenchymal stromal cells is influenced by tissue environment and physiopathological conditions.

Authors:  Serife Ayaz-Guner; Nicola Alessio; Mustafa B Acar; Domenico Aprile; Servet Özcan; Giovanni Di Bernardo; Gianfranco Peluso; Umberto Galderisi
Journal:  Cell Commun Signal       Date:  2020-07-29       Impact factor: 5.712

Review 2.  Mesenchymal stem cells and extracellular vesicles in therapy against kidney diseases.

Authors:  Yuling Huang; Lina Yang
Journal:  Stem Cell Res Ther       Date:  2021-03-31       Impact factor: 6.832

3.  Impaired immunomodulatory capacity in adipose tissue-derived mesenchymal stem/stromal cells isolated from obese patients.

Authors:  Xiang-Yang Zhu; Nattawat Klomjit; Sabena M Conley; Megan M Ostlie; Kyra L Jordan; Amir Lerman; Lilach O Lerman
Journal:  J Cell Mol Med       Date:  2021-08-21       Impact factor: 5.310

4.  Impact of combined therapy of mesenchymal stem cells and sitagliptin on a metabolic syndrome rat model.

Authors:  Yossra Ahmed; Zeinab Y Ali; Mona A Mohamed; Laila A Rashed; Ehsan K Mohamed
Journal:  J Diabetes Metab Disord       Date:  2021-03-31

Review 5.  Extracellular Vesicles from Human Adipose-Derived Mesenchymal Stem Cells: A Review of Common Cargos.

Authors:  Maria Luz Alonso-Alonso; Laura García-Posadas; Yolanda Diebold
Journal:  Stem Cell Rev Rep       Date:  2021-04-26       Impact factor: 5.739

Review 6.  Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles for Chronic Kidney Disease: Are We There Yet?

Authors:  Alfonso Eirin; Lilach O Lerman
Journal:  Hypertension       Date:  2021-06-28       Impact factor: 9.897

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.